Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outlook: An Intervention to Improve Quality of Life in Serious Illness Study

NCT01044290 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT01044290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01044290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outlook: An Intervention to Improve Quality of Life in Serious Illness Study
Lead sponsor
VA Office of Research and Development
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2011
Completion date
April 30, 2014
Enrollment
221 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, chronic obstructive pulmonary disease (copd), congestive heart failure (chf), end stage renal disease (esrd)